triazinate has been researched along with mitomycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlgren, JD; Falchuk, SC; Macdonald, JS; Neefe, JR; Schein, PS; Smith, FP; Treat, J; Woolley, PV | 1 |
| Hahn, RG; Moertel, CG; O'Connell, MJ; Schutt, AJ | 1 |
| Ahlgren, JD; Cazap, E; Estevez, RA; Marantz, A; Schein, PS; Smith, FP; Stein, J; Wilcosky, T; Woolley, PV | 1 |
1 trial(s) available for triazinate and mitomycin
| Article | Year |
|---|---|
FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Triazines | 1987 |
2 other study(ies) available for triazinate and mitomycin
| Article | Year |
|---|---|
Therapy of advanced gastric carcinoma. The Georgetown-Lombardi Cancer Center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Doxorubicin; Fluorouracil; Folic Acid Antagonists; Humans; Middle Aged; Mitomycin; Mitomycins; Prognosis; Remission Induction; Stomach Neoplasms; Streptozocin; Tegafur; Triazines | 1989 |
Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Stomach Neoplasms; Triazines | 1987 |